Shares of Vyne Therapeutics Inc (NASDAQ:VYNE) jumped 77.9% in premarket trading on Wednesday after the company unveiled a definitive agreement to merge with Yarrow Bioscience, a clinical-stage biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results